当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析 - 现金流量表

天康生物

(002100)

  

流通市值:90.52亿  总市值:90.52亿
流通股本:13.65亿   总股本:13.65亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金8,780,079,803.674,109,853,860.6418,388,189,563.5912,702,174,517.37
  收到的税费返还--186,573.06-
  收到其他与经营活动有关的现金40,870,453.3925,771,866.74325,408,916.2778,164,933.71
  经营活动现金流入小计8,820,950,257.064,135,625,727.3818,713,785,052.9212,780,339,451.08
  购买商品、接受劳务支付的现金6,199,354,467.433,608,282,340.5515,892,688,152.199,474,957,847.82
  支付给职工以及为职工支付的现金455,601,245.12213,539,576.71922,142,850.05531,793,500.67
  支付的各项税费75,917,849.0634,909,596.64191,566,113.81138,470,060.19
  支付其他与经营活动有关的现金471,051,234.09154,849,787.18545,522,630.55489,651,076.95
  经营活动现金流出小计7,201,924,795.74,011,581,301.0817,551,919,746.610,634,872,485.63
  经营活动产生的现金流量净额1,619,025,461.36124,044,426.31,161,865,306.322,145,466,965.45
二、投资活动产生的现金流量:
  收回投资收到的现金--49,000,000-
  取得投资收益收到的现金--91,124.24-
  处置固定资产、无形资产和其他长期资产收回的现金净额686,699.99-6,352,672.9533,066.65
  收到的其他与投资活动有关的现金---44,812,959.49
  投资活动现金流入小计686,699.99055,443,797.1944,846,026.14
  购建固定资产、无形资产和其他长期资产支付的现金179,118,903.5172,139,359.2626,462,554.36533,745,497.87
  投资支付的现金--179,000,000-
  支付其他与投资活动有关的现金---64,098,260.14
  投资活动现金流出小计179,118,903.5172,139,359.2805,462,554.36597,843,758.01
  投资活动产生的现金流量净额-178,432,203.52-72,139,359.2-750,018,757.17-552,997,731.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金--42,350,00031,500,000
  其中:子公司吸收少数股东投资收到的现金--42,350,00031,500,000
  取得借款收到的现金1,270,987,240.221,180,253,285.96,820,142,722.43,732,406,836.89
  收到其他与筹资活动有关的现金--680,520-
  筹资活动现金流入小计1,270,987,240.221,180,253,285.96,863,173,242.43,763,906,836.89
  偿还债务支付的现金2,474,714,726.361,067,710,0006,702,103,726.344,374,644,594.84
  分配股利、利润或偿付利息支付的现金380,793,238.339,756,510.02207,597,522.61172,155,228.87
  其中:子公司支付给少数股东的股利、利润--34,276,475.634,276,475.6
  支付其他与筹资活动有关的现金--84,341,092.12-
  筹资活动现金流出小计2,855,507,964.661,107,466,510.026,994,042,341.074,546,799,823.71
  筹资活动产生的现金流量净额-1,584,520,724.4472,786,775.88-130,869,098.67-782,892,986.82
五、现金及现金等价物净增加额-143,927,466.6124,691,842.98280,977,450.48809,576,246.76
  加:期初现金及现金等价物余额2,953,562,549.92,953,562,549.92,672,585,099.422,672,585,099.42
  期末现金及现金等价物余额2,809,635,083.33,078,254,392.882,953,562,549.93,482,161,346.18
补充资料:
  净利润409,618,129.4-596,421,188.04-
  资产减值准备29,163,891.72-22,737,961.15-
  固定资产和投资性房地产折旧344,520,747.08-685,161,599.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧344,520,747.08-685,161,599.31-
  无形资产摊销12,828,955.69-25,938,333.19-
  长期待摊费用摊销8,718,740.07-13,054,566.92-
  处置固定资产、无形资产和其他长期资产的损失423,913.1--4,500,658.4-
  固定资产报废损失36,962,429.05-28,459,691.97-
  公允价值变动损失-44,621.09--50,872.22-
  财务费用80,437,905-178,940,936.76-
  投资损失7,276,145.63-1,917,176.15-
  递延所得税-16,150,641.1--27,473,885.41-
  其中:递延所得税资产减少-16,057,576.05--26,961,341.66-
    递延所得税负债增加-93,065.05--512,543.75-
  存货的减少808,724,105.36-367,898,428.35-
  经营性应收项目的减少177,525,348.85--605,881,091.91-
  经营性应付项目的增加-365,454,339.01-9,475,486.01-
  其他---307,661,455.19-
  现金的期末余额2,809,635,083.3-2,953,562,549.9-
  减:现金的期初余额2,953,562,549.9-2,672,585,099.42-
  现金及现金等价物的净增加额-143,927,466.6-280,977,450.48-
公告日期2025-08-302025-04-302025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑